U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of Inspections and Investigations
  5. Diana Amador-Toro, Central Region (CER), Acting Regional Food and Drug Director (RFDD)
  1. Office of Inspections and Investigations

Diana Amador-Toro, Central Region (CER), Acting Regional Food and Drug Director (RFDD)

Blue Bar

 Diana Amador Toro

Diana Amador-Toro serves as the Central Region’s food and drug director in the Food and Drug Administration’s (FDA) Office of Regulatory Affairs (ORA). She is responsible for more than 700 field employees in seven districts and three laboratories. She has served as the chair of the Field Drug Committee and as the drug program manager for ORA since 2008.

Ms. Amador-Toro also served seven years as the district director in New Jersey, six years as the director of investigations, and four years as the science branch director in the San Juan District Office.  She was the first pre-approval manager in the field and held positions as drug specialist and investigator. Ms. Amador-Toro has more than 33 years of field experience in investigations and compliance activities. She has contributed to guidance documents of FDA and the International Conference on Harmonization and has conducted international training on good manufacturing practices and  pharmaceutical quality training in Argentina, Estonia, and England, among other countries. 
 

[Back to Office of Regulatory Affairs Senior Leadership Listing Home]

 

Back to Top